On Monday, September 1, Texas’s medical marijuana program will undergo its largest expansion since it was created a decade ago. House Bill 46, signed into law in June, broadens patient access, increases dosage limits, and adds new product options for the state’s Compassionate Use Program.
Category: News
Cannabis Use Linked to Lower Inflammation Among People With HIV or Methamphetamine Disorder
A new study led by researchers at San Diego State University and the University of California San Diego finds that cannabis use may help reduce inflammation in individuals with HIV and those with a history of methamphetamine use disorder (MUD). The research, published in the journal Viruses, involved 234 participants, including 86 people with HIV …
Trulieve Opens First Cincinnati Dispensary, Including Drive-Thru, Marking 238th Nationwide Location
Trulieve Cannabis Corp. has announced the opening of its first Cincinnati-area cannabis retail outlet, marking its 238th nationwide location. The new store, located at 3528 Columbia Parkway, will host a grand opening celebration Friday, August 29, featuring specials and giveaways. Operated by Harvest Grows LLC under the Trulieve brand through a licensing agreement, the dispensary …
Republican Congressman Tours Trulieve Facility, Highlights Medical Marijuana “Especially in the Veteran Community”
Republican Congressman Brian Mast recently visited a Trulieve medical marijuana facility, where he emphasized the role of cannabis in supporting veterans’ health. Mast, a veteran himself and a member of the bipartisan Congressional Cannabis Caucus, said discussions during the tour focused on “the benefits of medical marijuana, especially in the veteran community.”
Tilray Medical Expands Presence in Germany with Introduction of New Medical Cannabis Strains
Tilray Medical, a division of Tilray Brands, has announced the launch of three new EU-GMP certified medical cannabis strains for patients in Germany, further expanding its Good Supply product line. The new offerings include Good Supply Cannabisblüten THC 22 IIM, THC 25 MMK, and THC 18 LLD. Each will be sold in 15-gram jars for …
Study: THC and CBD Reduce Chemotherapy-Induced Nerve Pain, Improve Daily Function
Researchers at Tel Aviv Sourasky Medical Center have found that medical cannabis significantly eases chemotherapy-induced peripheral neuropathy (CIPN), a common and often debilitating side effect of cancer treatment. The study analyzed patient-reported outcomes from 751 individuals treated through the medical cannabis provider Tikun Olam. Participants reported symptoms such as burning, numbness, cold sensations, and prickling …
Study Explores Cannabis Compounds as Potential Tools Against COVID-19
Researchers from China’s Ministry of Agriculture and Rural Affairs and the Chinese Academy of Agricultural Science have reviewed evidence suggesting cannabis-derived compounds may hold therapeutic value in addressing COVID-19 and other respiratory infections. The review, published in the journal Foods, highlights that while vaccines remain central in controlling the spread of SARS-CoV-2, they are not …
Harvard Study: CBD Reduces Anxiety Symptoms in Pilot Clinical Trial
A new pilot clinical trial led by Harvard Medical School researchers finds that CBD may significantly reduce anxiety symptoms while also improving mood, sleep, and quality of life. The open-label study, published in Biomedicines, enrolled 12 patients with moderate to severe anxiety. Over six weeks, participants self-administered a full-spectrum, hemp-derived CBD sublingual solution containing 30 …
CBD Shows Unique Survival Benefit in Pancreatic Cancer Model, States Study
A new study published in the International Journal of Molecular Sciences provides fresh evidence that cannabidiol (CBD) could play a distinctive role in the treatment of pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive and deadly cancers. Researchers from the University of Parma, University College Cork, The University of Western Australia, and Curtin University …
MAPS Partners with Changemark to Advance $12.9 Million Cannabis PTSD Study for Veterans
The Multidisciplinary Association for Psychedelic Studies (MAPS) has taken a major step forward in its effort to study marijuana as a treatment option for veterans living with post-traumatic stress disorder. On Wednesday, MAPS announced it has selected Changemark Research + Evaluation as the contract research organization for its Phase 2 trial, known as MJP2, which …
Sponsored
